Rising to the Challenge: A Look at Targeted Treatment for NTRK Gene Fusion in Lung Cancer
[인터뷰] Park Se-hoon, Professor, Department of Hematology and Oncology, Samsung Hospital Seoul Professor Park Se-hoon pointed out: “The NTRK gene fusion is only expressed in a very limited number of cases of lung cancer, but since an effective treatment has been developed, active treatment is essential.” Since 1998, for more than 20 years, lung cancer […]
